Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results17.10.2023 - 2Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)21.11.2025
- 3California is completely free of drought for the first time in 25 years09.01.2026
- 4Former GLP-1 users regain lost weight after about 18 months, study says08.01.2026
- 5Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests15.11.2025
- Flu cases spiking this holiday season, CDC data shows
- Violence 'never part' of break-in plan, court told
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
- Northern lights chances rise for Christmas as space weather remains unsettled
- How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
- 5 Language Learning Applications
- Really focusing on Succulents: Tips and Procedures
- The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
- IDF: Staying in West Bank refugee camps will quell lone-wolf terror
